CA2402489C - Induction de tolerance orale grace a du collagene, afin de prevenir le rejet d'une allogreffe - Google Patents

Induction de tolerance orale grace a du collagene, afin de prevenir le rejet d'une allogreffe Download PDF

Info

Publication number
CA2402489C
CA2402489C CA2402489A CA2402489A CA2402489C CA 2402489 C CA2402489 C CA 2402489C CA 2402489 A CA2402489 A CA 2402489A CA 2402489 A CA2402489 A CA 2402489A CA 2402489 C CA2402489 C CA 2402489C
Authority
CA
Canada
Prior art keywords
col
lung
allograft
rejection
rats
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2402489A
Other languages
English (en)
Other versions
CA2402489A1 (fr
Inventor
David S. Wilkes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indiana University Research and Technology Corp
Original Assignee
Indiana University Research and Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indiana University Research and Technology Corp filed Critical Indiana University Research and Technology Corp
Publication of CA2402489A1 publication Critical patent/CA2402489A1/fr
Application granted granted Critical
Publication of CA2402489C publication Critical patent/CA2402489C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2402489A 2000-03-15 2001-03-15 Induction de tolerance orale grace a du collagene, afin de prevenir le rejet d'une allogreffe Expired - Lifetime CA2402489C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18942000P 2000-03-15 2000-03-15
US60/189,420 2000-03-15
PCT/US2001/008680 WO2001076617A2 (fr) 2000-03-15 2001-03-15 Induction de tolerance orale grace a du collagene, afin de prevenir le rejet d'une allogreffe

Publications (2)

Publication Number Publication Date
CA2402489A1 CA2402489A1 (fr) 2001-10-18
CA2402489C true CA2402489C (fr) 2011-11-01

Family

ID=22697251

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2402489A Expired - Lifetime CA2402489C (fr) 2000-03-15 2001-03-15 Induction de tolerance orale grace a du collagene, afin de prevenir le rejet d'une allogreffe

Country Status (3)

Country Link
AU (1) AU2001245848A1 (fr)
CA (1) CA2402489C (fr)
WO (1) WO2001076617A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593698A (en) * 1990-10-31 1997-01-14 Autoimmune, Inc. Suppression of proliferative response and induction of tolerance with polymorphic class II MHC allopeptides
US5962025A (en) * 1996-07-16 1999-10-05 The University Of Tennessee Research Corporation Method for treatment of systemic sclerosis and related fibrotic diseases

Also Published As

Publication number Publication date
CA2402489A1 (fr) 2001-10-18
AU2001245848A1 (en) 2001-10-23
WO2001076617A3 (fr) 2002-04-25
WO2001076617A2 (fr) 2001-10-18

Similar Documents

Publication Publication Date Title
Sumpter et al. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection
Yasufuku et al. Oral tolerance induction by type V collagen downregulates lung allograft rejection
Bach et al. Tolerance to islet autoantigens in type 1 diabetes
Maiuri et al. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients
EP2476435B1 (fr) Peptides immunogènes et leur utilisation dans les troubles immunitaires
Safinia et al. T-cell alloimmunity and chronic allograft dysfunction
CA2247071C (fr) Vaccination par adn destinee a l'induction d'une reponse immunodepressive des lymphocytes t
JP5980508B2 (ja) 自己免疫障害に対する処置方法
US9775880B2 (en) Methods of using myelin basis protein peptide compositions
WO2007136518A2 (fr) Traitement de troubles auto-immunitaires
EP0863155B1 (fr) Suppression de la prolifération des cellules T grâce à des fragments peptidiques de la protéine basique de la myéline
Ramírez et al. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein‐specific Th2 cell lines generated in the presence of glucocorticoids and IL‐4
EP2989121B1 (fr) Méthodes de préparation et composition de constructions peptidiques utiles pour le traitement de la polyarthrite rhumatoïde
JP2023525084A (ja) 多発性硬化症の処置のためのペプチド及び方法
US7348005B2 (en) Oral tolerance induction by collagen to prevent allograft rejection
Armenti et al. Pregnancy and transplantation
CA2402489C (fr) Induction de tolerance orale grace a du collagene, afin de prevenir le rejet d'une allogreffe
JP2023527205A (ja) 改良されたワクチン製剤
Wilkes The role of autoimmunity in the pathogenesis of lung allograft rejection
US20160158330A1 (en) Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
Salama et al. Brenner and rector's the kidney
WOOD et al. 21 Approaches to the Induction of Tolerance
Benson Efficacy and mechanisms of oral tolerance to myelin basic protein in relapsing experimental autoimmune encephalomyelitis
AU2014200368A1 (en) Immunogenic peptides and their use in immune disorders
Salama Tolerance: A Review of its Mechanisms in the Transplant Setting

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20210315